A Danshensu-Tetramethylpyrazine Conjugate DT-010 Overcomes Multidrug Resistance in Human Breast Cancer

Background: We previously demonstrated that a Danshensu-Tetramethylpyrazine conjugate DT-010 enhanced anticancer effect of doxorubicin (Dox) in Dox-sensitive human breast cancer cells, and protected against Dox-induced cardiotoxicity. This work was designed to see whether DT-010 overcomes Dox resist...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Pharmacol
Autori principali: Zhou, Xinhua, Wang, Anqi, Wang, Liang, Yin, Jianhua, Wang, Li, Di, Lijun, Hoi, Maggie Pui-Man, Shan, Luchen, Wu, Xu, Wang, Yuqiang
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2019
Soggetti:
Pharmacology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6606714/
https://ncbi.nlm.nih.gov/pubmed/31293428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.00722
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi